Metropolis Healthcare Ltd

#DiagnosticOncology has come a long way courtesy of technological advancement, precision oncology, and companion diagnostics culminating into optimal patient care. This #worldcancerday2023 , Dr Kirti Chadha, Chief Scientific Officer, Metropolis Labs joins other leading Oncology specialists to share her views with The Times of India on the advancements in diagnosis and treatment of cancer. #MolecularOncology #MetropolisScientificExpert #Cancer #Diagnosis #Oncomet #Research #Innovation #ScientificExcellence #Healthcare #MetropolisLab #DiagnosticOncology #worldcancerday2023 #MolecularOncology #MetropolisScientificExpert #Cancer #Diagnosis #Oncomet #Research #Innovation #ScientificExcellence #Healthcare #MetropolisLab

NERCON 2022 is the 31st Annual Conference of the Northeast Regional Chapter of the Indian Association of Pathologists and Microbiologists (NERC IAPM). It is the academic and scientific body of pathologists and microbiologists of 8 states of India which include 7 North Eastern States and Sikkim. Around 350 delegates attended this prestigious conference which had a series of scientific sessions and a trade fair. Metropolis Colleagues @Dr. Kirti Chadha, Chief Scientific Officer and Dr. K V Santosh, Senior Consultant Pathologist addressed a session on the updates of Breast and Lung Cancer – Morphology to Molecular and Gastrointestinal Mucosal Biopsies in Pathology, respectively. @Dr Ronica Baruah, Director & Chief of Lab Services, Quality Manager, Ekopath Metropolis Lab was the Organizing Secretary. #NERCON2022 #MolecularOncology #ScientificThoughtLeader #DiagnosticsLeader #NERCON2022 #MolecularOncology #ScientificThoughtLeader #DiagnosticsLeader

We are happy to inform you that #MetropolisSeniorScientificExpert @Dr Ronica Baruah, Director & Chief of Lab Services, Quality Manager, Ekopath Metropolis Lab played an instrumental role in executing the three-day conference of NERCON 2022, as an Organizing Secretary. #NERCON2022 #MolecularOncology #ScientificThoughtLeader #DiagnosticsLeader #MetropolisSeniorScientificExpert #NERCON2022 #MolecularOncology #ScientificThoughtLeader #DiagnosticsLeader

What are #HereditaryCancers? What are its symptoms? What type of regular tests one should consider for the diagnosis of Hereditary Cancers? Find about the same in the below episode of #HealthMeet of #LifeandMore Plus, in which our #MetropolisScientificExpert Dr Shaikhali Barodawala, (Head of the Department of Surgical Pathology and Integrated Oncopathology Division, GRL, Metropolis Healthcare) speaks on #HereditaryCancers in detail. #HereditaryBreastandOvarianCancer #HBOC #MolecularOncology #MolecularGenomics #Genetictesting #Cancer #Oncology #MetropolisLab #Healthcare #BRCA #NextGenBRCAhttps://www.youtube.com/watch?v=Nl0XEiX0Ntk #HereditaryCancers #HealthMeet #LifeandMore #MetropolisScientificExpert #HereditaryBreastandOvarianCancer #HBOC #MolecularOncology #MolecularGenomics #Genetictesting #Cancer #Oncology #MetropolisLab #Healthcare #BRCA #NextGenBRCA

#Genetictesting plays an integral part in diagnosing and treating lung cancer. Genetic testing looks for mutations which help develop tailored treatment plans. Using Genetic testing, one can identify changes in lung cells that may trigger and contribute to cancer growth – “Biomarkers”. Identifying the biomarkers helps Oncologist arrive at the best approach to treatment. These targeted therapies are less invasive than traditional cancer treatments because they do not destroy healthy cells – they stop the cancer cells from growing and reproducing.” – says #MetropolisScientificexpert Dr Kirti Chadha, (Chief Scientific Officer, Metropolis Healthcare) in her interview to #Onlymyhealth. Find out more in this article, as she elaborates on the importance of Genetic testing in early detection, and treatment of #LungCancer. Want to know more about the Genetic testing available at Metropolis, write to our experts on medconnect@metropolisindia.com #MetropolisLabs #Healthcare #Oncology #Cancer #LungCancer #Diagnosis #Leadingdiagnosticplayer #Lungcancertesting #BRCA #NextGenBRCA #MolecularOncology #Research #Innovation #accesstohealthcare #Affordablediagnosishttps://www.onlymyhealth.com/genetic-testing-lung-cancer-importance-1661016165 #Genetictesting #MetropolisScientificexpert #Onlymyhealth #LungCancer #MetropolisLabs #Healthcare #Oncology #Cancer #Diagnosis #Leadingdiagnosticplayer #Lungcancertesting #BRCA #NextGenBRCA #MolecularOncology #Research #Innovation #accesstohealthcare #Affordablediagnosis

In an exclusive interaction with #Onlymyhealth, our #MetropolisScientificExpert Dr. Kavita Munjal, Technical Operations Head – Madhya Pradesh speaks about the prevalence of Breast Cancer and the need for awareness that can help in early detection and treatment. #MetropolisHealthcare #Breastcancerawareness #BreastCancertesting #BreastCancerdiagnosis #Diagnostictesting #Scientificexcellence #BRCA #MolecularGenomics #Genomexpert #MolecularOncologyhttps://www.onlymyhealth.com/breast-cancer-raise-awareness-and-prevention-1661172660 #Onlymyhealth #MetropolisScientificExpert #MetropolisHealthcare #Breastcancerawareness #BreastCancertesting #BreastCancerdiagnosis #Diagnostictesting #Scientificexcellence #BRCA #MolecularGenomics #Genomexpert #MolecularOncology

Check out this insightful interview of Dr Kirti Chadha, Chief Scientific Officer, Metropolis Labs, as she speaks to Financial Express (India) on the significance of ‘Noninvasive prenatal testing (NIPT)’ which is done to determine the risk that the fetus will be born with certain genetic abnormalities. In this article, she highlights the importance of such tests, scope of #genomics in India, #geneticabnormalities, among others. #MolecularGenomics #MetropolisInnovationCell #NextGenNIPT #NextGenBRCA #MolecularOncology #Genomexpert #Gynecexpert #Oncomet #genomics #geneticabnormalities #MolecularGenomics #MetropolisInnovationCell #NextGenNIPT #NextGenBRCA #MolecularOncology #Genomexpert #Gynecexpert #Oncomet

#BreastCancer and #OvarianCancer are the most common forms of cancer in women and constitute a major cause of cancer related mortality in women. Around 10-15% of breast cancers are attributed to mutations or alterations in #BReastCAncerGene (BRCA ½) genes, causing 40-50% of #hereditarybreastcancers. Experts suggest that the early risk detection of breast cancer through genetic testing can help in better management. In this article covered in #Onlymyhealth, Dr. Monisha Banerjee, Senior Consultant, Molecular Genomics and Genetic Counselling, Metropolis Healthcare Limited speaks on the significance of #Genetictesting, Pre & Post Counselling for the early detection of Breast Cancer risk. Want to know more about the Breast Cancer Gene Test available at Metropolis, write to our experts on medconnect@metropolisindia.com #Research #BRCA #Healthcare #Cancerscreening #HBOC #genomics #molecularoncology #metropolisinnovationcell #innovation #oncomethttps://www.onlymyhealth.com/genetic-counseling-breast-cancer-risk-1656941880 #BreastCancer #OvarianCancer #BReastCAncerGene #hereditarybreastcancers #Onlymyhealth #Genetictesting #Research #BRCA #Healthcare #Cancerscreening #HBOC #genomics #molecularoncology #metropolisinnovationcell #innovation #oncomet

Mutations or abnormalities in the BRCA1 (BReast CAncer Gene 1) and BRCA2 genes are the most common cause of hereditary breast cancer. In the Indian population, there is a higher proportion of BRCA1- associated breast cancer (66%) than BRCA2 (45%). Men with a BRCA mutation, especially BRCA2 are also at a higher risk of Breast Cancer (6-8%). Dr. Aparna Rajadhyaksha, Medical Consultant, Metropolis Healthcare contributes an insightful article to The New Indian Express explaining the significance of Breast Cancer Gene Testing and its impact on treatment. To read the online version, click here: https://www.newindianexpress.com/cities/kochi/2022/jul/05/breast-cancer-genetic-testing-impact-and-advantages-2472883.html#BRCA1 #BRCA2 #BreastCancer #OvarianCancer #LungCancer #Genetesting #ProstateCancer #Genomexpert #Oncomet #ScientificExcellence #MetropolisInnovationCell #MolecularOncology #BRCA1 #BRCA2 #BreastCancer #OvarianCancer #LungCancer #Genetesting #ProstateCancer #Genomexpert #Oncomet #ScientificExcellence #MetropolisInnovationCell #MolecularOncology